Trade Summary

Yesterday, Sandler Laura Lee, serving as Chief Operating Officer at Oruka Therapeutics, Inc. (ORKA), sold 600 shares at $69.69 per share, for a total transaction value of $41,814.00. Following this transaction, Sandler Laura Lee now holds 236,384 shares of ORKA.

This sale represents a 0.25% decrease in Sandler Laura Lee's stake in the company.

The trade was executed on Monday, June 15, 2026 and publicly disclosed via SEC Form 4 filing on Monday, June 15, 2026 at 6:51 PM ET, meaning the disclosure happened on the same day as the trade.

Oruka Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.